Rossari Biotech Limited — PPTs, 20-10-2024: Investor Presentation

Rossari Biotech Limited reported its Q2 FY25 earnings, showcasing a 3.1% year-on-year revenue growth to ₹498.4 crore, with a 7.3% increase in PAT to ₹35.3 crore. The company highlights strong export performance, growth in the Home, Personal Care, and Performance Chemicals segment, and strategic expansions through acquisitions, including a new subsidiary in the UAE. Management emphasized commitment to sustainable practices and innovation, aiming for continued growth with a resilient business model despite market challenges.